Health Care Up After Lilly Earnings -- Health Care Roundup

Published: 2026-04-30 17:44:28 ET VKTX

Published on 04/30/2026 at 05:44 pm EDT

Health-care companies rose after strong earnings from one obesity-drug giant.

Booming sales of weight-loss shots fueled strong revenue and profit growth for Eli Lilly in the latest quarter, as robust consumer demand helped offset falling prices for the drugs. Shares of Lilly soared. Rival weight-loss drug makers Novo Nordisk rose in sympathy.

Viking Therapeutics fell after it posted a wider quarterly loss than investors had anticipated.

Cigna Group will exit the Affordable Care Act market next year, the latest sign of turmoil in a business that has been hit hard by the loss of federal subsidies.

Drug wholesaler Cardinal Health boosted its earnings projection for the fiscal year.

Write to Rob Curran at [email protected]

(END) Dow Jones Newswires

04-30-26 1743ET